Hutch News

Hutch News

Stories tagged 'Human Biology'

Brain cancer subtype caused by single gene fusion

Hutch researchers create genetically relevant model to examine the biology of supratentorial ependymomas

June 26, 2018 | By Sabrina Richards / Fred Hutch News Service

Dr. Eric Holland and colleagues create a genetically relevant model to examine the biology of supratentorial ependymomas, a common brain cancer in children.

View story >


Nanoparticles take immunotherapy in new direction

Hutch scientist to use nanoparticles to reprogram macrophages to tackle brain tumors

May 30, 2018 | By Sabrina Richards / Fred Hutch News Service

Dr. Fan Zhang has received funding from the American Brain Tumor Association to develop nanoparticles that can tackle a type of brain cancer called glioblastoma.

View story >


A focus on partnerships at Hutch/Merck summit

Research on the immune system aims to stop infectious diseases and cancer

May 11, 2018 | By Sabin Russell / Fred Hutch News Service

Article about a daylong Infectious Disease Summit hosted by Fred Hutch May 10 in Seattle.

View story >


Functional genomics provides a window into cancer's Achilles heels

Technique pinpoints unique tumor vulnerabilities — even when they are not written in tumor DNA

May 10, 2018 | By Sabrina Richards / Fred Hutch News Service

New findings by Dr. Christopher Kemp and colleagues demonstrate how functional genomics can highlight potential drug targets in patients with head and neck cancer.

View story >


Study shows how glioblastomas get a leg up

New computational method sheds light on how cancer-contributing genes make brain tumors more aggressive and radiation-resistant

April 13, 2018 | By Sabrina Richards / Fred Hutch News Service

Researchers at Fred Hutch and the Dana-Farber Cancer Institute have developed a computational method that sheds light on how cancer-contributing genes make brain tumors more aggressive and radiation-resistant.

View story >


Early phase clinical trial shows promise for advanced head and neck cancer

Nine out of 10 patients treated with the experimental therapy saw their tumors shrink

April 13, 2018 | By Rachel Tompa / Fred Hutch News Service

When you look at Carla Stone, you might not guess that she was diagnosed with stage 4 head and neck cancer just two years ago. Stone participated in a clinical trial that shrank her advanced tumor down to nothing, allowing her to undergo a minimally invasive surgery.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.